Blossom Mak
Camperdown, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Erratum to 'Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma' [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644].
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 12, 2025
Characterising the effect of circulating sphingolipids on metastatic prostate cancer cells.
Journal: EBioMedicine
Published: January 22, 2025
Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: November 04, 2024
Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate Cancer.
Journal: JCO clinical cancer informatics
Published: July 25, 2023
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer.
Journal: Prostate cancer and prostatic diseases
Published: November 15, 2022
Targeting lipid metabolism in metastatic prostate cancer.
Journal: Therapeutic advances in medical oncology
Published: August 25, 2022
GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol).
Journal: Therapeutic advances in medical oncology
Published: February 07, 2022
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase.
Journal: EBioMedicine
Published: September 05, 2021
Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancer.
Journal: Prostate cancer and prostatic diseases
Published: October 19, 2020
Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growth.
Journal: The Journal of pathology
Published: October 19, 2020
Last Updated: 09/26/2026